ID

24632

Beschreibung

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Link

https://clinicaltrials.gov/ct2/show/NCT00291876

Stichworte

Versionen (1)
  1. 10.08.17 10.08.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

10. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

GSK Hepatitis A Vaccine Month 138 Visit 18 SAE continued NCT00291876

Englisch

GSK Hepatitis A Vaccine Month 138 SAE continued NCT00291876

1 Formulare  
Study administration
Beschreibung

Study administration

Subject Number
Beschreibung

Subject Identifier

Datentyp

integer

Alias
UMLS CUI [1]
C2348585
Study vaccine Information
Beschreibung

Study vaccine Information

Vaccine
Beschreibung

(specify mixed or separate)

Datentyp

text

Alias
UMLS CUI [1]
C0042210
Dose No
Beschreibung

Dose Number

Datentyp

integer

Alias
UMLS CUI [1,1]
C1115464
UMLS CUI [1,2]
C0042210
UMLS CUI [1,3]
C1519255
Lot No
Beschreibung

Lot Number

Datentyp

integer

Alias
UMLS CUI [1,1]
C2826710
UMLS CUI [1,2]
C0042210
Route / Site
Beschreibung

Administration Route

Datentyp

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0042210
Date
Beschreibung

administration date

Datentyp

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0042210
Concomitant medication / vaccination that could have contributed to this SAE
Beschreibung

Concomitant medication / vaccination that could have contributed to this SAE

Drug / vaccine
Beschreibung

concomitant medication

Datentyp

text

Alias
UMLS CUI [1]
C2347852
Dosage
Beschreibung

Dosage

Datentyp

text

Alias
UMLS CUI [1]
C0178602
Frequency
Beschreibung

Frequency

Datentyp

text

Alias
UMLS CUI [1]
C3476109
Route
Beschreibung

Route

Datentyp

text

Alias
UMLS CUI [1]
C0013153
Start Date
Beschreibung

concomitant medication start date

Datentyp

date

Alias
UMLS CUI [1]
C2826734
End Date
Beschreibung

concomitant medication end date

Datentyp

date

Alias
UMLS CUI [1]
C2826744
Relevant intercurrent illness & medical history that could have contributed to this SAE
Beschreibung

Relevant intercurrent illness & medical history that could have contributed to this SAE

Condition
Beschreibung

Condition

Datentyp

text

Alias
UMLS CUI [1]
C0012634
Still present?
Beschreibung

Condition still present

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C1519255
Drug(s) used to treat this SAE
Beschreibung

Drug(s) used to treat this SAE

Drug
Beschreibung

Drug

Datentyp

text

Alias
UMLS CUI [1]
C0013227
Dosage
Beschreibung

Dosage

Datentyp

text

Alias
UMLS CUI [1]
C0178602
Frequency
Beschreibung

Frequency

Datentyp

text

Alias
UMLS CUI [1]
C3476109
Route
Beschreibung

Route

Datentyp

text

Alias
UMLS CUI [1]
C0013153
Start date
Beschreibung

drug start date

Datentyp

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
End Date
Beschreibung

drug end date

Datentyp

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Surgical treatment for this SAE
Beschreibung

Surgical treatment for this SAE

Surgical treatment for this SAE, please specify
Beschreibung

Surgical treatment

Datentyp

text

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C1519255
Description
Beschreibung

Description

Description (provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)
Beschreibung

Description

Datentyp

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1519255
AEGIS number
Beschreibung

AEGIS number

Datentyp

text

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C0600091
Comments
Beschreibung

Comments

Comments
Beschreibung

Comments

Datentyp

text

Alias
UMLS CUI [1]
C0947611
Zum Seitenanfang zurückkehren

Ähnliche Modelle

GSK Hepatitis A Vaccine Month 138 SAE continued NCT00291876

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
Study vaccine Information
Vaccine
Item
Vaccine
text
C0042210 (UMLS CUI [1])
Dose Number
Item
Dose No
integer
C1115464 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Lot Number
Item
Lot No
integer
C2826710 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Administration Route
Item
Route / Site
text
C0013153 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
administration date
Item
Date
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Item Group
Concomitant medication / vaccination that could have contributed to this SAE
concomitant medication
Item
Drug / vaccine
text
C2347852 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
concomitant medication start date
Item
Start Date
date
C2826734 (UMLS CUI [1])
concomitant medication end date
Item
End Date
date
C2826744 (UMLS CUI [1])
Item Group
Relevant intercurrent illness & medical history that could have contributed to this SAE
Condition
Item
Condition
text
C0012634 (UMLS CUI [1])
Condition still present
Item
Still present?
boolean
C2745955 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Item Group
Drug(s) used to treat this SAE
Drug
Item
Drug
text
C0013227 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
drug start date
Item
Start date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
drug end date
Item
End Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Surgical treatment for this SAE
Surgical treatment
Item
Surgical treatment for this SAE, please specify
text
C0543467 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Description
Description
Item
Description (provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)
text
C0678257 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
AEGIS number
Item
AEGIS number
text
C0237753 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Comments
Comments
Item
Comments
text
C0947611 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video